 |
|
||||||
|
|
||||||
On 5 September, the JSPS Stockholm Office held a colloquium on the topic “Advances in Cellular Reprogramming and Stem Cell Biology.” Venued at the Karolinska Institute (KI) in Stockholm, the colloquium was attended by some 70 people. In this era when advanced aging and changing dietary habits are proliferating such diseases as Alzheimer’s, cancer and diabetes, keen interest is converging on regenerative medicines that can reprogram cells and restore the function of organs impaired by disease. Riding the crest of this wave of interest, the colloquium featured presentations by Prof. Shinya Yamanaka, director, Center for iPS Cell Research and Application, Kyoto University, and five other researchers from the Center. Starting with Prof. Yamanaka’s success in generating induced pluripotent stem (iPS) cells from human skin tissue, the Center has taken a world lead in the subject field of research. Along with presentations on advances on the leading edge of iPS cell research, presentations were also delivered on embryonic stem cells and a wide range of cutting-edge work by researchers from KI, Ludwig Institute for Cancer Research Ltd, Umeå University, Lund University, and University of Turku. Some of the research achievements reported will be published in next year’s edition of the international journal Experimental Cell Research. - JSPS Stockholm Office  |
